Coronary stent DynamX™

cobalt-chromiumpolymerdrug eluting

The DynamX™ Drug Eluting Coronary Bioadaptor System is a significant innovation in the treatment of coronary artery disease. Going beyond drug-eluting stents (DES), DynamX represents one of the most significant breakthroughs in implant design in the past 30 years. DynamX is the first coronary artery implant designed to adapt to vessel physiology by: Maintaining the ability for positive adaptive remodeling Restoring vessel function Allowing for return towards baseline angulation The loss of vessel movement, which occurs with DES, has been associated with major adverse cardiac events (MACE).13 By adapting to the vessel, DynamX offers the potential to reduce the incidence of MACE. DynamX is not approved by the United States Food and Drug Administration (FDA). HOW DYNAMX WORKS DynamX is a cobalt chromium implant coated in a proven bioresorbable polymer and a low-dose anti-proliferative drug. It is designed to deploy similarly to a DES and initially support the coronary artery during vessel healing. Over six months, the polymer coating is intended to resorb. This frees unique “uncaging elements” on the device. The uncaging is designed to allow DynamX to move along with the natural expansion and contraction of the vessel. These uncaging elements are located at low stress regions of the device’s sinusoidal rings that are intended to move safely and independently within the frame of the bioadaptor